Pay in 4 interest-free payments of $6.43 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
So your doctor may need to adjust your dosage of these drugs if you are taking a GLP-1
CagriSema combines semaglutide with cagrilintide (an amylin receptor agonist), targeting yet another hormone pathway involved in appetite regulation
Over a year, that difference adds up to significant metabolic impact
PMC 4970552
KEY DETAILS Program starts July 1, 2026 Flat $50 patient copay No deductible Only 28- or 30-day fills A new PA is required when switching medications Prescribers do not need to be enrolled in Medicare, but cannot be on the CMS Preclusion List Please share this with prescribers, pharmacists, nurses, medical assistants, and prior authorization teams
Our goal is to provide a clear, science-backed path to sustainable health
